A detailed history of Cannell Capital LLC transactions in Mimedx Group, Inc. stock. As of the latest transaction made, Cannell Capital LLC holds 2,433,494 shares of MDXG stock, worth $16.9 Million. This represents 4.44% of its overall portfolio holdings.

Number of Shares
2,433,494
Previous 2,480,969 1.91%
Holding current value
$16.9 Million
Previous $21.8 Million 13.88%
% of portfolio
4.44%
Previous 5.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$7.61 - $8.63 $361,284 - $409,709
-47,475 Reduced 1.91%
2,433,494 $18.7 Million
Q4 2023

Feb 13, 2024

BUY
$5.7 - $9.14 $1.18 Million - $1.89 Million
207,207 Added 9.11%
2,480,969 $21.8 Million
Q3 2023

Nov 14, 2023

BUY
$6.35 - $8.16 $7.45 Million - $9.58 Million
1,173,506 Added 106.66%
2,273,762 $16.6 Million
Q2 2023

Aug 14, 2023

BUY
$3.14 - $6.61 $2.19 Million - $4.6 Million
696,594 Added 172.57%
1,100,256 $7.27 Million
Q1 2023

May 15, 2023

BUY
$2.97 - $4.81 $1.2 Million - $1.94 Million
403,662 New
403,662 $1.38 Million

Others Institutions Holding MDXG

About MIMEDX GROUP, INC.


  • Ticker MDXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 113,609,000
  • Market Cap $787M
  • Description
  • MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins. The company's patented and proprietary pr...
More about MDXG
Track This Portfolio

Track Cannell Capital LLC Portfolio

Follow Cannell Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cannell Capital LLC with notifications on news.